Powered by

Rush University Medical Center Assigned Patent for Identifying Rapidly Progressing Lung Cancer

Aug 03, 2019 - Targeted News Service

ALEXANDRIA, Va., Aug. 3 -- Rush University Medical Center, Chicago, Illinois, has been assigned a patent (No. 10,365,281, initially filed Dec. 8, 2014) developed by two co-inventors for "biomarkers of rapid progression in advanced non-small cell lung cancer." The co-inventors are Jeffrey A. Borgia, Chicago, Illinois, and Sanjib Basu, Chicago, Illinois.

The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=...